Dementia and Primary Care Provider: Managing Challenging Behaviors - Live Webinar 6/21/2022
Primary care providers often feel uncomfortable in making treatment recommendations for the management of behavioral and psychological symptoms in patients with dementia (BPSD). This activity outlines the evidence base for non-pharmacologic management of BPSD.
Physicians, PCPS, PAs, NPs, Nurses and other healthcare professionals interested in geriatric care
Participants at the conclusion of this webinar will be able to:
Faculty Presenter and sole member of the planning committee, does not have anything to disclose with regard to commercial interests.
Faculty member does plan on discussing unlabeled/investigational uses of haloperidol, mirtazapine, trazodone, melatonin, raelteon, suvarexant, donepezil, rivastigmine, galantamine, valproate, carbamazepine,oxcarbazepine, citalopram, sertraline, risperidone, olanzapine, quetiapine.
The following planning committee members from Boston University School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships with ineligible companies: Michael Burk, BS – Senior Program Manager
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation